MedTrace Logo

Vertebral Fracture and Osteonecrosis Associated With High-dose Glucocorticoid

NCT00679978 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2009-09-18

No results posted yet for this study

Summary

Osteoporotic vertebral fracture (VF) and osteonecrosis of the femoral head (OFH) are major concerns in patients with systemic rheumatic diseases treated with high-dose glucocorticoids (GCs). The investigators examined and compared the incidence and risk factors of VF with those of OFH in patients who had recently received high-dose GC therapy to clarify the relationship between these two complications.

Conditions

  • Vertebral Fracture
  • Osteonecrosis
  • Rheumatic Diseases

Sponsors & Collaborators

  • Saitama Medical University

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Primary Completion
2007-10-31
Completion
2007-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00679978 on ClinicalTrials.gov